Cover Image
Market Research Report
Product code 
1037383

Global Ranibizumab Market Size, Status and Forecast 2022

Published: | QYResearch | 89 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Ranibizumab Market Size, Status and Forecast 2022
Published: November 19, 2021
QYResearch
Content info: 89 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.

Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.

Market Analysis and Insights: Global Ranibizumab Market

The global Ranibizumab market size is projected to reach US$ 1848 million by 2027, from US$ 3380.3 million in 2020, at a CAGR of -9.9% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ranibizumab market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ranibizumab market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ranibizumab market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ranibizumab market.

Global Ranibizumab Scope and Market Size

Ranibizumab market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ranibizumab market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

  • Glass Vial
  • Prefilled Syringe

Segment by Application

  • Wet AMD
  • Complications of Diabetes
  • RVO
  • Others

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

By Company

  • Roche
  • Novartis
Table of Contents

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Ranibizumab Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Glass Vial
    • 1.2.3 Prefilled Syringe
  • 1.3 Market by Application
    • 1.3.1 Global Ranibizumab Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Wet AMD
    • 1.3.3 Complications of Diabetes
    • 1.3.4 RVO
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Ranibizumab Market Perspective (2016-2027)
  • 2.2 Ranibizumab Growth Trends by Regions
    • 2.2.1 Ranibizumab Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Ranibizumab Historic Market Share by Regions (2016-2021)
    • 2.2.3 Ranibizumab Forecasted Market Size by Regions (2022-2027)
  • 2.3 Ranibizumab Industry Dynamic
    • 2.3.1 Ranibizumab Market Trends
    • 2.3.2 Ranibizumab Market Drivers
    • 2.3.3 Ranibizumab Market Challenges
    • 2.3.4 Ranibizumab Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Ranibizumab Players by Revenue
    • 3.1.1 Global Top Ranibizumab Players by Revenue (2016-2021)
    • 3.1.2 Global Ranibizumab Revenue Market Share by Players (2016-2021)
  • 3.2 Global Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Ranibizumab Revenue
  • 3.4 Global Ranibizumab Market Concentration Ratio
    • 3.4.1 Global Ranibizumab Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Ranibizumab Revenue in 2020
  • 3.5 Ranibizumab Key Players Head office and Area Served
  • 3.6 Key Players Ranibizumab Product Solution and Service
  • 3.7 Date of Enter into Ranibizumab Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Ranibizumab Breakdown Data by Type

  • 4.1 Global Ranibizumab Historic Market Size by Type (2016-2021)
  • 4.2 Global Ranibizumab Forecasted Market Size by Type (2022-2027)

5 Ranibizumab Breakdown Data by Application

  • 5.1 Global Ranibizumab Historic Market Size by Application (2016-2021)
  • 5.2 Global Ranibizumab Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Ranibizumab Market Size (2016-2027)
  • 6.2 North America Ranibizumab Market Size by Type
    • 6.2.1 North America Ranibizumab Market Size by Type (2016-2021)
    • 6.2.2 North America Ranibizumab Market Size by Type (2022-2027)
    • 6.2.3 North America Ranibizumab Market Size by Type (2016-2027)
  • 6.3 North America Ranibizumab Market Size by Application
    • 6.3.1 North America Ranibizumab Market Size by Application (2016-2021)
    • 6.3.2 North America Ranibizumab Market Size by Application (2022-2027)
    • 6.3.3 North America Ranibizumab Market Size by Application (2016-2027)
  • 6.4 North America Ranibizumab Market Size by Country
    • 6.4.1 North America Ranibizumab Market Size by Country (2016-2021)
    • 6.4.2 North America Ranibizumab Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Ranibizumab Market Size (2016-2027)
  • 7.2 Europe Ranibizumab Market Size by Type
    • 7.2.1 Europe Ranibizumab Market Size by Type (2016-2021)
    • 7.2.2 Europe Ranibizumab Market Size by Type (2022-2027)
    • 7.2.3 Europe Ranibizumab Market Size by Type (2016-2027)
  • 7.3 Europe Ranibizumab Market Size by Application
    • 7.3.1 Europe Ranibizumab Market Size by Application (2016-2021)
    • 7.3.2 Europe Ranibizumab Market Size by Application (2022-2027)
    • 7.3.3 Europe Ranibizumab Market Size by Application (2016-2027)
  • 7.4 Europe Ranibizumab Market Size by Country
    • 7.4.1 Europe Ranibizumab Market Size by Country (2016-2021)
    • 7.4.2 Europe Ranibizumab Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Ranibizumab Market Size (2016-2027)
  • 8.2 Asia-Pacific Ranibizumab Market Size by Type
    • 8.2.1 Asia-Pacific Ranibizumab Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Ranibizumab Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Ranibizumab Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Ranibizumab Market Size by Application
    • 8.3.1 Asia-Pacific Ranibizumab Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Ranibizumab Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Ranibizumab Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Ranibizumab Market Size by Region
    • 8.4.1 Asia-Pacific Ranibizumab Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Ranibizumab Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Ranibizumab Market Size (2016-2027)
  • 9.2 Latin America Ranibizumab Market Size by Type
    • 9.2.1 Latin America Ranibizumab Market Size by Type (2016-2021)
    • 9.2.2 Latin America Ranibizumab Market Size by Type (2022-2027)
    • 9.2.3 Latin America Ranibizumab Market Size by Type (2016-2027)
  • 9.3 Latin America Ranibizumab Market Size by Application
    • 9.3.1 Latin America Ranibizumab Market Size by Application (2016-2021)
    • 9.3.2 Latin America Ranibizumab Market Size by Application (2022-2027)
    • 9.3.3 Latin America Ranibizumab Market Size by Application (2016-2027)
  • 9.4 Latin America Ranibizumab Market Size by Country
    • 9.4.1 Latin America Ranibizumab Market Size by Country (2016-2021)
    • 9.4.2 Latin America Ranibizumab Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Ranibizumab Market Size (2016-2027)
  • 10.2 Middle East & Africa Ranibizumab Market Size by Type
    • 10.2.1 Middle East & Africa Ranibizumab Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Ranibizumab Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Ranibizumab Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Ranibizumab Market Size by Application
    • 10.3.1 Middle East & Africa Ranibizumab Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Ranibizumab Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Ranibizumab Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Ranibizumab Market Size by Country
    • 10.4.1 Middle East & Africa Ranibizumab Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Ranibizumab Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Ranibizumab Introduction
    • 11.1.4 Roche Revenue in Ranibizumab Business (2016-2021)
    • 11.1.5 Roche Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Ranibizumab Introduction
    • 11.2.4 Novartis Revenue in Ranibizumab Business (2016-2021)
    • 11.2.5 Novartis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

List of Tables

  • Table 1. Global Ranibizumab Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
  • Table 2. Key Players of Glass Vial
  • Table 3. Key Players of Prefilled Syringe
  • Table 4. Global Ranibizumab Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
  • Table 5. Global Ranibizumab Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
  • Table 6. Global Ranibizumab Market Size by Regions (2016-2021) & (US$ Million)
  • Table 7. Global Ranibizumab Market Share by Regions (2016-2021)
  • Table 8. Global Ranibizumab Forecasted Market Size by Regions (2022-2027) & (US$ Million)
  • Table 9. Global Ranibizumab Market Share by Regions (2022-2027)
  • Table 10. Ranibizumab Market Trends
  • Table 11. Ranibizumab Market Drivers
  • Table 12. Ranibizumab Market Challenges
  • Table 13. Ranibizumab Market Restraints
  • Table 14. Global Ranibizumab Revenue by Players (2016-2021) & (US$ Million)
  • Table 15. Global Ranibizumab Market Share by Players (2016-2021)
  • Table 16. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranibizumab as of 2020)
  • Table 17. Ranking of Global Top Ranibizumab Companies by Revenue (US$ Million) in 2020
  • Table 18. Global 5 Largest Players Market Share by Ranibizumab Revenue (CR5 and HHI) & (2016-2021)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Ranibizumab Product Solution and Service
  • Table 21. Date of Enter into Ranibizumab Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Ranibizumab Market Size by Type (2016-2021) (US$ Million)
  • Table 24. Global Ranibizumab Revenue Market Share by Type (2016-2021)
  • Table 25. Global Ranibizumab Forecasted Market Size by Type (2022-2027) (US$ Million)
  • Table 26. Global Ranibizumab Revenue Market Share by Type (2022-2027) & (US$ Million)
  • Table 27. Global Ranibizumab Market Size Share by Application (2016-2021) & (US$ Million)
  • Table 28. Global Ranibizumab Revenue Market Share by Application (2016-2021)
  • Table 29. Global Ranibizumab Forecasted Market Size by Application (2022-2027) (US$ Million)
  • Table 30. Global Ranibizumab Revenue Market Share by Application (2022-2027) & (US$ Million)
  • Table 31. North America Ranibizumab Market Size by Type (2016-2021) (US$ Million)
  • Table 32. North America Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
  • Table 33. North America Ranibizumab Market Size by Application (2016-2021) (US$ Million)
  • Table 34. North America Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
  • Table 35. North America Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
  • Table 36. North America Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
  • Table 37. Europe Ranibizumab Market Size by Type (2016-2021) (US$ Million)
  • Table 38. Europe Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
  • Table 39. Europe Ranibizumab Market Size by Application (2016-2021) (US$ Million)
  • Table 40. Europe Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
  • Table 41. Europe Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
  • Table 42. Europe Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
  • Table 43. Asia-Pacific Ranibizumab Market Size by Type (2016-2021) (US$ Million)
  • Table 44. Asia-Pacific Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
  • Table 45. Asia-Pacific Ranibizumab Market Size by Application (2016-2021) (US$ Million)
  • Table 46. Asia-Pacific Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
  • Table 47. Asia-Pacific Ranibizumab Market Size by Region (2016-2021) & (US$ Million)
  • Table 48. Asia-Pacific Ranibizumab Market Size by Region (2022-2027) & (US$ Million)
  • Table 49. Latin America Ranibizumab Market Size by Type (2016-2021) (US$ Million)
  • Table 50. Latin America Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
  • Table 51. Latin America Ranibizumab Market Size by Application (2016-2021) (US$ Million)
  • Table 52. Latin America Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
  • Table 53. Latin America Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
  • Table 54. Latin America Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
  • Table 55. Middle East & Africa Ranibizumab Market Size by Type (2016-2021) (US$ Million)
  • Table 56. Middle East & Africa Ranibizumab Market Size by Type (2022-2027) & (US$ Million)
  • Table 57. Middle East & Africa Ranibizumab Market Size by Application (2016-2021) (US$ Million)
  • Table 58. Middle East & Africa Ranibizumab Market Size by Application (2022-2027) & (US$ Million)
  • Table 59. Middle East & Africa Ranibizumab Market Size by Country (2016-2021) & (US$ Million)
  • Table 60. Middle East & Africa Ranibizumab Market Size by Country (2022-2027) & (US$ Million)
  • Table 61. Roche Company Details
  • Table 62. Roche Business Overview
  • Table 63. Roche Ranibizumab Product
  • Table 64. Roche Revenue in Ranibizumab Business (2016-2021) & (US$ Million)
  • Table 65. Roche Recent Development
  • Table 66. Novartis Company Details
  • Table 67. Novartis Business Overview
  • Table 68. Novartis Ranibizumab Product
  • Table 69. Novartis Revenue in Ranibizumab Business (2016-2021) & (US$ Million)
  • Table 70. Novartis Recent Development
  • Table 71. Research Programs/Design for This Report
  • Table 72. Key Data Information from Secondary Sources
  • Table 73. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Ranibizumab Market Share by Type: 2020 VS 2027
  • Figure 2. Glass Vial Features
  • Figure 3. Prefilled Syringe Features
  • Figure 4. Global Ranibizumab Market Share by Application: 2020 VS 2027
  • Figure 5. Wet AMD Case Studies
  • Figure 6. Complications of Diabetes Case Studies
  • Figure 7. RVO Case Studies
  • Figure 8. Others Case Studies
  • Figure 9. Ranibizumab Report Years Considered
  • Figure 10. Global Ranibizumab Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 11. Global Ranibizumab Market Size (US$ Million), 2016 VS 2021 VS 2027
  • Figure 12. Global Ranibizumab Market Share by Regions: 2020 VS 2027
  • Figure 13. Global Ranibizumab Market Share by Regions (2022-2027)
  • Figure 14. Global Ranibizumab Market Share by Players in 2020
  • Figure 15. Global Top Ranibizumab Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranibizumab as of 2020
  • Figure 16. The Top 10 and 5 Players Market Share by Ranibizumab Revenue in 2020
  • Figure 17. Global Ranibizumab Revenue Market Share by Type (2016-2021)
  • Figure 18. Global Ranibizumab Revenue Market Share by Type (2022-2027)
  • Figure 19. North America Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 20. North America Ranibizumab Market Share by Type (2016-2027)
  • Figure 21. North America Ranibizumab Market Share by Application (2016-2027)
  • Figure 22. North America Ranibizumab Market Share by Country (2016-2027)
  • Figure 23. United States Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 24. Canada Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 25. Europe Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 26. Europe Ranibizumab Market Share by Type (2016-2027)
  • Figure 27. Europe Ranibizumab Market Share by Application (2016-2027)
  • Figure 28. Europe Ranibizumab Market Share by Country (2016-2027)
  • Figure 29. Germany Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 30. France Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 31. U.K. Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 32. Italy Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 33. Russia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 34. Nordic Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 35. Asia-Pacific Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 36. Asia-Pacific Ranibizumab Market Share by Type (2016-2027)
  • Figure 37. Asia-Pacific Ranibizumab Market Share by Application (2016-2027)
  • Figure 38. Asia-Pacific Ranibizumab Market Share by Region (2016-2027)
  • Figure 39. China Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 40. Japan Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 41. South Korea Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 42. Southeast Asia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 43. India Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 44. Australia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 45. Latin America Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 46. Latin America Ranibizumab Market Share by Type (2016-2027)
  • Figure 47. Latin America Ranibizumab Market Share by Application (2016-2027)
  • Figure 48. Latin America Ranibizumab Market Share by Country (2016-2027)
  • Figure 49. Mexico Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 50. Brazil Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 51. Middle East & Africa Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 52. Middle East & Africa Ranibizumab Market Share by Type (2016-2027)
  • Figure 53. Middle East & Africa Ranibizumab Market Share by Application (2016-2027)
  • Figure 54. Middle East & Africa Ranibizumab Market Share by Country (2016-2027)
  • Figure 55. Turkey Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 56. Saudi Arabia Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 57. UAE Ranibizumab Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 58. Roche Revenue Growth Rate in Ranibizumab Business (2016-2021)
  • Figure 59. Novartis Revenue Growth Rate in Ranibizumab Business (2016-2021)
  • Figure 60. Bottom-up and Top-down Approaches for This Report
  • Figure 61. Data Triangulation
  • Figure 62. Key Executives Interviewed